Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Dermatologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 33Pain, Postoperative 4Chronic Pain 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Breast Diseases 2Brain Neoplasms 2Agnosia 2Vulvodynia 1Uterine Cervical Neoplasms 1Skin Diseases 1Seroma 1Recurrence 1Radiation Injuries 1Postoperative Hemorrhage 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms by Site 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Hot Flashes 1Hodgkin Disease 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Gangliosidosis, GM1 1Gangliosidoses 1

Interventions

Surveys and Questionnaires 7Nivolumab 5atezolizumab 3Radiosurgery 3Blood Specimen Collection 3pertuzumab 2pembrolizumab 2pazopanib 2cemiplimab 2amminedichloro(2-methylpyridine)platinum(II) 2alectinib 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Drug Therapy 2Capecitabine 2tepotinib 1talazoparib 1selpercatinib 1pralsetinib 1ponatinib 1pemigatinib 1palbociclib 1motexafin gadolinium 1montanide ISA 51 1mannide monooleate 1itacitinib 1ipatasertib 1fludarabine 1entrectinib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Sodium Chloride × Breast × Clear all
NCT04899908 2026-03-19

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Brigham and Women's Hospital

Phase 2 Active not recruiting
134 enrolled
BreastCNSDermatologicGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡